Skip to main content
Premium Trial:

Request an Annual Quote

We're Seeking Consensus from a Ouija Board and a Magic 8 Ball

Daniel MacArthur at Genetic Future has a blog post listing what he considers "some of the major trends that will play out in the human genomics field in 2009 - both in terms of research outcomes, and shifts in the rapidly-evolving consumer genomics industry," he writes. Among them: increased focus on rare variants in common diseases; "a proliferation of new companies attempting to gain a share of the personal genomics market, most of whom will sink rapidly into obscurity"; and no way, he says, that a complete genome sequence will be offered for a retail price of less than $1,000.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.